Daily Reporter

Today Don't Miss

Today Don't Miss

Are we reaching a turning point in metastatic prostate cancer?

At yesterday’s Presidential Symposium, a Late-Breaking Abstract presentation of the PROfound study reported a clinically meaningful benefit in radiological progression-free survival (PFS) with olaparib in men with BRCA1, BRCA2 or ATM mutations in metastatic castration-resistant…

Read More


Finding the right balance to manage frail patients

Managing frail patients reminds us of one of the biggest challenges in oncology – the need to treat the right patients, not all patients. Frailty is generally accepted as a state of vulnerability to adverse…

Read More